Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis - An open pilot study

Journal of Crohn's and Colitis

Volumn 7, Issue 4, 2013, Pages 271-279

  Biedermann, Luc ^a   Mwinyi, Jessica ^a   Scharl, Michael ^a   Frei, Pascal ^a   Zeitz, Jonas ^a   Kullak Ublick, Gerd A ^a   Vavricka, Stephan R ^a,b   Fried, Michael ^a   Weber, Achim ^a   Humpf, Hans Ulrich ^c,d   Peschke, Simone ^e   Jetter, Alexander ^a   Krammer, Gerhard ^e   Rogler, Gerhard ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b TRIEMLI HOSPITAL   (Switzerland)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d NRW Graduate School of Chemistry   (Germany)

^e SYMRISE AG   (Germany)

Author keywords

Antioxidants; Clinical trials; Complementary and alternative medicine; Nutrition; Ulcerative colitis

Indexed keywords

ANTHOCYANIN; C REACTIVE PROTEIN; CALGRANULIN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ACTIVITY; ENDOSCOPY; FECES LEVEL; FEMALE; FOLLOW UP; FRUIT JUICE; HISTOLOGY; HUMAN; HUMAN EXPERIMENT; MALE; MAYO SCORE; PILOT STUDY; PRIORITY JOURNAL; RATING SCALE; REMISSION; RILEY INDEX; TREATMENT RESPONSE; ULCERATIVE COLITIS; VACCINIUM MYRTILLUS;

ADOLESCENT; ADULT; AGED; ANTHOCYANINS; ANTIOXIDANTS; COLITIS, ULCERATIVE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; FRUIT; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHYTOTHERAPY; PILOT PROJECTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SIGMOIDOSCOPY; TREATMENT OUTCOME; VACCINIUM MYRTILLUS; YOUNG ADULT;

EID: 84875261582     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.07.010     Document Type: Article

References (46)

1. Bernstein C.N., Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut 2008, 57:1185-1191. 10.1136/gut.2007.122143.
2. Sutherland L., Macdonald J.K. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2006, CD000544. 10.1002/14651858.CD000544.pub2.
3. Faubion W.A., Loftus E.V., Harmsen W.S., Zinsmeister A.R., Sandborn W.J. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001, 121:255-260.
4. Timmer A., McDonald J.W.D., Macdonald J.K. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2007, CD000478. 10.1002/14651858.CD000478.pub2.
5. Fraser A.G., Orchard T.R., Jewell D.P. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut 2002, 50:485-489.
6. Rogler G., Bernstein C.N., Sood A., Goh K.L., Yamamoto-Furusho J.K., Abbas Z., et al. Role of biological therapy for inflammatory bowel disease in developing countries. Gut 2012, 61(5):706-712. Published Online First: 13 October 2011. 10.1136/gutjnl-2011-300613.
7. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000, 130:2073S-2085S.
8. Manach C., Scalbert A., Morand C., Rémésy C., Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004, 79:727-747.
9. Hertog M.G.L., Feskens E.J.M., Kromhout D., Hollman P.C.H., Katan M.B. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993, 342:1007-1011. 10.1016/0140-6736(93)92876-U.
10. Gu L., Kelm M.A., Hammerstone J.F., Beecher G., Holden J., Haytowitz D., et al. Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J Nutr 2004, 134:613-617.
11. Manach C., Williamson G., Morand C., Scalbert A., Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81:230S-242S.
12. Heinonen M. Antioxidant activity and antimicrobial effect of berry phenolics - a Finnish perspective. Mol Nutr Food Res 2007, 51:684-691. 10.1002/mnfr.200700006.
13. Ovaskainen M., Törrönen R., Koponen J.M., Sinkko H., Hellström J., Reinivuo H., et al. Dietary intake and major food sources of polyphenols in Finnish adults. J Nutr 2008, 138:562-566.
14. Määttä-Riihinen K.R., Kamal-Eldin A., Mattila P.H., González-Paramás A.M., Törrönen A.R. Distribution and contents of phenolic compounds in eighteen Scandinavian berry species. J Agric Food Chem 2004, 52:4477-4486. 10.1021/jf049595y.
15. Nyman N.A., Kumpulainen J.T. Determination of anthocyanidins in berries and red wine by high-performance liquid chromatography. J Agric Food Chem 2001, 49:4183-4187.
16. Mauray A., Felgines C., Morand C., Mazur A., Scalbert A., Milenkovic D. Bilberry anthocyanin-rich extract alters expression of genes related to atherosclerosis development in aorta of apo E-deficient mice. Nutr Metab Cardiovasc Dis 2010, 10.1016/j.numecd.2010.04.011.
17. Karlsen A., Paur I., Bøhn S., Sakhi A., Borge G., Serafini M., et al. Bilberry juice modulates plasma concentration of NF-κB related inflammatory markers in subjects at increased risk of CVD. Eur J Nutr 2010, 49:345-355. 10.1007/s00394-010-0092-0.
18. Toivanen M., Huttunen S., Lapinjoki S., Tikkanen-Kaukanen C. Inhibition of adhesion of Neisseria meningitidis to human epithelial cells by berry juice polyphenolic fractions. Phytother Res 2011, 25:828-832. 10.1002/ptr.3349.
19. Ashour O.M., Elberry A.A., Alahdal A., Al Mohamadi A.M., Nagy A.A., Abdel-Naim A.B., et al. Protective effect of bilberry (Vaccinium myrtillus) against doxorubicin-induced oxidative cardiotoxicity in rats. Med Sci Monit 2011, 17:BR110-BR115.
20. Granfeldt Y., Bjorck I. A bilberry drink with fermented oatmeal decreases postprandial insulin demand in young healthy adults. Nutr J 2011, 10:57.
21. Thomasset S., Berry D.P., Cai H., West K., Marczylo T.H., Marsden D., et al. Pilot study of oral anthocyanins for colorectal cancer chemoprevention. Cancer Prev Res 2009, 2:625-633.
22. Rezaie A., Parker R., Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?. Dig Dis Sci 2007, 52:2015-2021. 10.1007/s10620-006-9622-2.
23. Grisham M.B., Granger D.N. Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites. Dig Dis Sci 1988, 33:6S-15S.
24. Babbs C.F. Oxygen radicals in ulcerative colitis. Free Radic Biol Med 1992, 13:169-181.
25. Wu L., Xu Z., Di Dong He S., Yu H. Protective effect of anthocyanins extract from blueberry on TNBS-induced IBD model of mice. eCAM 2010, neq040.
26. Osman N., Adawi D., Ahrné S., Jeppsson B., Molin G. Probiotics and blueberry attenuate the severity of dextran sulfate sodium (DSS)-induced colitis. Dig Dis Sci 2008, 53:2464-2473. 10.1007/s10620-007-0174-x.
27. Montrose D.C., Horelik N.A., Madigan J.P., Stoner G.D., Wang L., Bruno R.S., et al. Anti-inflammatory effects of freeze-dried black raspberry powder in ulcerative colitis. Carcinogenesis 2011, 32:343-350.
28. Piberger H., Oehme A., Hofmann C., Dreiseitel A., Sand P.G., Obermeier F., et al. Bilberries and their anthocyanins ameliorate experimental colitis. Mol Nutr Food Res 2011, 55:1724-1729. 10.1002/mnfr.201100380.
29. Riley S.A., Mani V., Goodman M.J., Dutt S., Herd M.E. Microscopic activity in ulcerative colitis: what does it mean?. Gut 1991, 32:174-178.
30. Travis S.P.L., Stange E.F., Lémann M., Øresland T., Bemelman W.A., Colombel J.F., et al. European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis 2008, 2:24-62.
31. Ardizzone S., Maconi G., Russo A., Imbesi V., Colombo E., Bianchi Porro G. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 2006, 55:47-53. 10.1136/gut.2005.068809.
32. Gonzalez-Lama Y., Gisbert J., Mate J. The role of tacrolimus in inflammatory bowel disease: a systematic review. Dig Dis Sci 10/01/2006, 51:1833-1840.
33. Oren R., Arber N., Odes S., Moshkowitz M., Keter D., Pomeranz I., et al. Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial. Gastroenterology 1996, 110:1416-1421.
34. Sood A., Midha V., Makharia G.K., Ahuja V., Singal D., Goswami P., et al. The probiotic preparation, VSL3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol 2009, 7:1202-1209. [1209.e1]. 10.1016/j.cgh.2009.07.016.
35. Feagan B.G., Greenberg G.R., Wild G., Fedorak R.N., Paré P., McDonald J.W.D., et al. Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin. N Engl J Med 2005, 352:2499-2507. 10.1056/NEJMoa042982.
36. Su C., Lewis J.D., Goldberg B., Brensinger C., Lichtenstein G.R. A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis. Gastroenterology 2007, 132:516-526. 10.1053/j.gastro.2006.12.037.
37. Del Rio D., Borges G., Crozier A. Berry flavonoids and phenolics: bioavailability and evidence of protective effects. Br J Nutr 2010, 67-90.
38. Kühnau J. The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 1976, 24:117-191.
39. Boivin D., Blanchette M., Barrette S., Moghrabi A. Inhibition of cancer cell proliferation and suppression of TNF-induced activation of NFkappaB by edible berry juice. Anticancer Res 2007, 27:937-948.
40. Huang C., Huang Y., Li J., Hu W., Aziz R., Tang M., et al. Inhibition of benzo(a)pyrene diol-epoxide-induced transactivation of activated protein 1 and nuclear factor kappaB by black raspberry extracts. Cancer Res 2002, 62:6857-6863.
41. Selma M.V., Espín J.C., Tomás-Barberán F.A. Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem 2009, 57:6485-6501. 10.1021/jf902107d.
42. Parkar S.G., Stevenson D.E., Skinner M.A. The potential influence of fruit polyphenols on colonic microflora and human gut health. Int J Food Microbiol 2008, 124:295-298. 10.1016/j.ijfoodmicro.2008.03.017.
43. Vendrame S., Guglielmetti S., Riso P., Arioli S., Klimis-Zacas D., Porrini M. Six-week consumption of a wild blueberry powder drink increases bifidobacteria in the human gut. J Agric Food Chem 2011, 10.1021/jf2028686.
44. Lee H.C., Jenner A.M., Low C.S., Lee Y.K. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res Microbiol 2006, 157:876-884. 10.1016/j.resmic.2006.07.004.
45. Bränning C., Håkansson Å., Ahrné S., Jeppsson B., Molin G., Nyman M. Blueberry husks and multi-strain probiotics affect colonic fermentation in rats. Br J Nutr 2009, 101:859-870.
46. Håkansson A., Bränning C., Adawi D., Molin G., Nyman M., Jeppsson B., et al. Blueberry husks, rye bran and multi-strain probiotics affect the severity of colitis induced by dextran sulphate sodium. Scand J Gastroenterol 2009, 44:1213-1225. 10.1080/00365520903171268.